This project describes studies of hematopoietic reconstitution after marrow transplantation. The frequency and clinical significance of mixed hemopoietic and lymphoid chimerism after marrow transplantation will be evaluated. Patients with donors of the opposite sex will be studied for hematopoietic chimerism of various cell populations including B-cells, T-cells, committed hematopoietic progenitors cultured directly and from long-term marrow cultures, and marrow microenvironmental cells that form the adherent cell layers in long-term marrow cultures. The techniques used will involve clonal expansion of each of these cell populations. SV-40 virus will be used to transform and develop clones of microenvironmental cells and EB virus will be used to transform B-cells. The second part of this project will be an examination of pre- colony forming hematopoietic progenitors in manipulated marrow samples from normal donors and from recipients of allogeneic marrow. These studies rely on the recent observations that by using monoclonal antibodies directed against myeloid differentiation antigens, it is possible to define and measure a progenitor cell that does not form colonies but has the capability of producing multipotent and unipotent colony-forming progenitors in long-term marrow culture. These assay systems will be employed to examine the proliferative defect present in vitro after marrow transplantation and to measure the earliest detectable hematopoietic progenitors in marrows subjected to manipulations such as T-cell depletion which appear to increase the risk of graft rejection. Since it is possible to measure the proliferative potential of these early progenitors in the absence of potentially growth-modulating cell populations, it should be possible to determine whether the in vitro proliferative defect after marrow grafting is due to a decrease in number and/or proliferative capacity of early progenitors or due to growth modulation in vitro by other cell populations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018029-13
Application #
3819926
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
Shaw, Bronwen E; Syrjala, Karen L; Onstad, Lynn E et al. (2018) PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. Cancer 124:841-849
Jamani, Kareem; Onstad, Lynn E; Bar, Merav et al. (2018) Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2271-2276
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Armenian, Saro H; Yang, Dongyun; Teh, Jennifer Berano et al. (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2:1756-1764
Petersdorf, Effie W; Stevenson, Philip; Malkki, Mari et al. (2018) Patient HLA Germline Variation and Transplant Survivorship. J Clin Oncol 36:2524-2531
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580

Showing the most recent 10 out of 1845 publications